Company / Named in our posts
Vincerx.
Follow VincerxVincerx’s pipeline includes antibody-drug conjugates, a small molecule-drug conjugate, a CDK9 inhibitor, and a bioconjugation platform.[1]
02Deals
Deals on Carrywatch
Every deal that names Vincerx, and its role in each.
Vincerx / QumulusAI
Vincerx and QumulusAI outline proposed business combination
See deal detailsVincerx / Oqory
Vincerx Pharma and Oqory Amend Business Combination Terms
See deal detailsDeal Web
Vincerx and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Vincerx reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Vincerx:
- P01Vincerx Pharma, Inc.: Vincerx / QumulusAI
18 Mar 2025
- P02Vincerx Pharma, Inc.: Vincerx / Oqory
6 Feb 2025